Enrique Alvarez, MD
Neurology · Aurora, CONPI 1790822054
Payments from drug & device makers
Across 972 payments — averaging $14,762 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$8.3M
- E.r. Squibb & Sons, L.L.C.$2M
- Genentech, Inc.$2M
- Biogen$955K
- Sanofi$437K
- TG Therapeutics, Inc.$150K
- plus $430K from 20 others
Across 59 payments — averaging $2094.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biohaven Pharmaceuticals, Inc.$46K
- EMD Serono Research & Development Institute, Inc.$43K
- TG Therapeutics, Inc.$21K
- Novartis$9K
- Sanofi US Services Inc.$2K
- AbbVie$1K
- plus $1K from 2 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 183 | $8,339,740 |
| E.r. Squibb & Sons, L.L.C. | 14 | $2,021,985 |
| Genentech, Inc. | 74 | $2,015,519 |
| Biogen | 103 | $954,506 |
| Sanofi | 121 | $436,514 |
| TG Therapeutics, Inc. | 98 | $150,361 |
| F. Hoffmann-la Roche AG | 38 | $133,062 |
| Roche Products Limited | 12 | $107,462 |
| Genentech USA, Inc. | 92 | $74,111 |
| EMD Serono, Inc. | 69 | $20,585 |
| Novartis Pharma AG | 10 | $18,309 |
| Amgen(2 entities) | 38 | $17,632 |
| Hoffmann-la Roche Limited | 6 | $14,762 |
| AstraZeneca | 27 | $14,569 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $12,600 |
| Bristol Myers Squibb | 61 | $4,093 |
| Merck Kgaa | 1 | $3,225 |
| Janssen Global Services, LLC | 4 | $3,129 |
| Greenwich Biosciences, Inc. | 1 | $2,856 |
| Mallinckrodt Hospital Products Inc. | 1 | $2,280 |
| Banner Life Sciences, LLC | 1 | $800 |
| Janssen Scientific Affairs, LLC | 5 | $347 |
| Actelion Pharmaceuticals, Ltd | 3 | $314 |
| Teva Pharmaceuticals USA, Inc. | 1 | $79 |
| Amneal Pharmaceuticals LLC | 1 | $26 |
| Medtronic | 1 | $18 |
How this compares
$14,348,883 in reported general payments places this provider in the 95th percentile of 334 neurology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Aurora
- Timothy VollmerAurora$2M
- Jeffrey BennettAurora$1.9M
- Anna ShahAurora$1.4M
- John CorboyAurora$1.3M
- Amanda PiquetAurora$1.3M
- Drew KernAurora$1.2M
- Maureen LeeheyAurora$1.1M
- Thomas RagoleAurora$841K
- Denise DamekAurora$733K
- Sana AslamAurora$695K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.